BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16732758)

  • 1. Topiramate for smoking cessation.
    Khazaal Y; Cornuz J; Bilancioni R; Zullino DF
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):384-8. PubMed ID: 16732758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.
    Reid MS; Palamar J; Raghavan S; Flammino F
    Psychopharmacology (Berl); 2007 May; 192(1):147-58. PubMed ID: 17345064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
    Anthenelli RM; Blom TJ; McElroy SL; Keck PE
    Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
    Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
    Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of abstinence on cigarette consumption upon the resumption of smoking.
    Wellman RJ; DiFranza JR; Savageau JA; Godiwala S; Savageau N; Friedman K; Hazelton J
    Addict Behav; 2006 Apr; 31(4):711-6. PubMed ID: 15982825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential interest of topiramate in addiction.
    Thorens G; Billieux J; Manghi R; Khan R; Khazaal Y; Zullino DF
    Curr Pharm Des; 2011; 17(14):1410-5. PubMed ID: 21524260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
    Ma JZ; Johnson BA; Yu E; Weiss D; McSherry F; Saadvandi J; Iturriaga E; Ait-Daoud N; Rawson RA; Hrymoc M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D; McCann M; Pham T; Stock C; Dickinson R; Elkashef A; Li MD
    Drug Alcohol Depend; 2013 Jun; 130(1-3):45-51. PubMed ID: 23142494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms.
    Khazaal Y; Zullino DF
    J Clin Psychopharmacol; 2009 Apr; 29(2):192-3; author reply 193-4. PubMed ID: 19512990
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
    Johnson BA; Ait-Daoud N; Akhtar FZ; Javors MA
    Arch Intern Med; 2005 Jul; 165(14):1600-5. PubMed ID: 16043677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topiramate in substance-related and addictive disorders].
    Cohen J; Dervaux A; Laqueille X
    Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotective effects of topiramate].
    Pappalardo A; Liberto A; Patti F; Reggio A
    Clin Ter; 2004; 155(2-3):75-8. PubMed ID: 15244111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive reduction using nicotine gum as a prelude to quitting.
    Jiménez-Ruiz CA; Ulibarri MM; Besada NA; Guerrero AC; Garcia AG; Cuadrado AR
    Nicotine Tob Res; 2009 Jul; 11(7):847-50. PubMed ID: 19443787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate in the treatment of compulsive sexual behavior: case report.
    Khazaal Y; Zullino DF
    BMC Psychiatry; 2006 May; 6():22. PubMed ID: 16719909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial.
    Reis AD; Castro LA; Faria R; Laranjeira R
    Braz J Psychiatry; 2008 Jun; 30(2):132-5. PubMed ID: 18470406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot trial of topiramate for the treatment of cocaine dependence.
    Kampman KM; Pettinati H; Lynch KG; Dackis C; Sparkman T; Weigley C; O'Brien CP
    Drug Alcohol Depend; 2004 Sep; 75(3):233-40. PubMed ID: 15283944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G; Diener HC; Pfeil J; Schwalen S
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.
    Kobylecki C; Hill MP; Crossman AR; Ravenscroft P
    Mov Disord; 2011 Nov; 26(13):2354-63. PubMed ID: 21953539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.